Skip to main content
. 2021 Feb 5;23(3):513–523. doi: 10.1177/1099800421991656

Figure 2.

Figure 2.

Predicted MetaCyc pathways that were differentially abundant between participants with high-occurring symptoms and participants with low co-occurring systems before chemotherapy and radiation therapy (CRT), based on linear discriminant analysis (LDA) for effect size.